Publicaciones en las que colabora con Mohamad Yehia El-Mir El-Halak (34)

2010

  1. Metformin prevents experimental gentamicin-induced nephropathyby a mitochondria-dependent pathway

    Kidney International, Vol. 77, Núm. 10, pp. 861-869

2007

  1. Inhibition of the intestinal absorption of bile acids using cationic derivatives: Mechanism and repercussions

    Biochemical Pharmacology, Vol. 73, Núm. 3, pp. 394-404

  2. Novel bile acid derivatives (BANBs) with cytostatic activity obtained by conjugation of their side chain with nitrogenated bases

    Biochemical Pharmacology, Vol. 73, Núm. 9, pp. 1394-1404

2003

  1. Sensitivity of bile acid transport by organic anion-transporting polypeptides to intracellular pH

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1611, Núm. 1-2, pp. 249-257

2002

  1. Changes in the pattern of bile acids in the nuclei of rat liver cells during hepatocarcinogenesis

    Clinical Science, Vol. 102, Núm. 2, pp. 143-150

  2. Changes in the pool of bile acids in hepatocyte nuclei during rat liver regeneration

    Journal of Hepatology, Vol. 36, Núm. 4, pp. 534-542

  3. Chronic renal failure-induced changes in serum and urine bile acid profiles

    Digestive Diseases and Sciences, Vol. 47, Núm. 11, pp. 2398-2406

  4. Relationship between asymptomatic hypercholanaemia of pregnancy and progesterone metabolism

    Clinical Science, Vol. 102, Núm. 5, pp. 587-593

2001

  1. Increased levels of typically fetal bile acid species in patients with hepatocellular carcinoma

    Clinical Science, Vol. 100, Núm. 5, pp. 499-508

1999

  1. Cholephilic characteristics of a new cytostatic complex of cisplatin with glycocholate (Bamet-R2)

    Journal of Controlled Release, Vol. 57, Núm. 2, pp. 161-169

1998

  1. Alteraciones del metabolismo

    Fundamentos de fisiopatología (McGraw-Hill Interamericana de España), pp. 485-505

  2. Fetal excretion of the fluorescent bile acid derivative cholylglycylamido-fluorescein (FITC-GC) by the rat placenta-maternal liver tandem

    Placenta, Vol. 19, Núm. 1, pp. 119-126

  3. In vitro test to determine the effect of cytostatic drugs on co-cultured rat hepatocytes and hepatoma cells

    International Journal of Experimental Pathology, Vol. 79, Núm. 2, pp. 109-115

  4. Rat liver transport and biotransformation of a cytostatic complex of bis-cholylglycinate and platinum (II)

    Journal of Hepatology, Vol. 28, Núm. 3, pp. 417-425

  5. Transient enterohepatic circulation and enhanced biliary versus urinary excretion of the cytostatic drug bischolylglycinate-chloroplatinum(II) (Bamet-H2)

    International Journal of Pharmaceutics, Vol. 172, Núm. 1-2, pp. 79-88

  6. Transport and biotransformation of the new cytostatic complex cis- diammineplatinum(II)-chlorocholylglycinate (Bamet-R2) by the rat liver

    Journal of Lipid Research, Vol. 39, Núm. 9, pp. 1792-1798

1997

  1. Bile acid secretion during synchronized rat liver regeneration

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1362, Núm. 1, pp. 56-66

  2. Effect of bile acids on hepatobiliary transport of cisplatin by perfused rat liver

    Pharmacology and Toxicology, Vol. 80, Núm. 3, pp. 111-117

  3. Effect of maternal cholestasis on biliary lipid and bile acid secretion in the infant rat

    Hepatology, Vol. 26, Núm. 3, pp. 527-536

1995

  1. ATP-dependent bile acid transport across microvillous membrane of human term trophoblast

    American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 268, Núm. 4 31-4